Microsurgical Treatment for Typical Pituitary Apoplexy with 44 Patients, According to Two Pathological Stages

Abstract

Objects: The aim of this study was to explore the pathogenesis of typical pituitary apoplexy in different periods, to help to formulate a reasonable treatment program and to select the correct operation time.

Methods: Forty-four cases with pituitary apoplexy were diagnosed by the clinical presentation, pathological examination and surgical findings. Clinical manifestation, imaging features, surgical and pathological findings, as well as their relationships with the courses of this disease were analyzed retrospectively.

Results: The course of typical pituitary apoplexy was divided into two stages (the early hemorrhagic infarct stage and the late necrosis stage). The total removal rates in the early and late stage were 87.5% (14/16) and 100% (28/28), respectively.

Conclusions: Typical pituitary apoplexy is mainly caused by hemorrhage secondary to necrosis after infarction. The staging of this disease provides an important guidance value to diagnosis and treatment. The surgical outcomes in the late stage were significantly better than those in the early stage. The patients without significant symptoms can be conservatively treated by hormone substitution therapy.

Key words

pituitary adenoma - pituitary apoplexy - microsurgical treatment

References

• 1 Cardoso ER, Peterson EW. Pituitary apoplexy: a review.  Neurosurgery. 1984;  14 363-373
• 2 Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients.  Neurosurgery. 1990;  26 980-986
• 3 Bills DC, Meyer FB, Laws ER. et al . A retrospective analysis of pituitary apoplexy.  Neurosurgery. 1993;  33 602-608 ; discussion 608–609 
• 4 Milazzo S, Toussaint P, Proust F. et al . Ophthalmologic aspects of pituitary apoplexy.  Eur J Ophthalmol. 1996;  6 69-73
• 5 Lubina A, Olchovsky D, Berezin M. et al . Management of pituitary apoplexy: clinical experience with 40 patients.  Acta Neurochir (Wien). 2005;  147 151-157 ; discussion 157 
• 6 Sibal L, Ball SG, Connolly V. et al . Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.  Pituitary. 2004;  7 157-163
• 7 Alhajje A, Lambert M, Crabbe J. Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report.  J Neurosurg. 1985;  63 288-292
• 8 Otsuka F, Kageyama J, Ogura T. et al . Pituitary apoplexy induced by a combined anterior pituitary test: case report and literature review.  Endocr J. 1998;  45 393-398
• 9 Silberstein L, Johnston C, Bhagat A. et al . Pituitary apoplexy during induction chemotherapy for acute myeloid leukaemia.  Br J Haematol. 2008;  143 151
• 10 Semple PL, Jane JA, Laws ER. Clinical relevance of precipitating factors in pituitary apoplexy.  Neurosurgery. 2007;  61 956-961 ; discussion 961-962 
• 11 Muthukumar N, Rossette D, Soundaram M. et al . Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome.  J Clin Neurosci. 2008;  15 873-879
• 12 Nielsen EH, Lindholm J, Bjerre P. et al . Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma.  Clin Endocrinol (Oxf). 2006;  64 319-322
• 13 Parikh VP, Talwar I. Computed tomography of hemorrhage in a pituitary adenoma without apoplexy.  J Comput Tomogr. 1988;  12 187-189
• 14 Semple PL, Jane JA, Lopes MB. et al . Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results.  J Neurosurg. 2008;  108 909-915
• 15 Chuang CC, Chang CN, Wei KC. et al . Surgical treatment for severe visual compromised patients after pituitary apoplexy.  J Neurooncol. 2006;  80 39-47
• 16 Agrawal D, Mahapatra AK. Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes.  Surg Neurol. 2005;  63 42-46 ; discussion 46 
• 17 Mou C, Han T, Zhao H. et al . Clinical features and immunohistochemical changes of pituitary apoplexy.  J Clin Neurosci. 2009;  16 64-68
• 18 Armstrong MR, Douek M, Schellinger D. et al . Regression of pituitary macroadenoma after pituitary apoplexy: CT and MR studies.  J Comput Assist Tomogr. 1991;  15 832-834
• 19 Landolt AM, Froesch ER, Konig MP. Spontaneous postoperative normalization of growth hormone levels in two patients with acromegaly not cured by transsphenoidal surgery.  Neurosurgery. 1988;  23 634-637

Correspondence